• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Anthroposophic supportive treatment in children with medulloblastoma receiving first-line therapy.

作者信息

Seifert Georg, Rutkowski Stefan, Jesse Patrick, Madeleyn Rene, Reif Marcus, Henze Günter, Längler Alfred

机构信息

Department of Pediatric Oncology and Hematology, Otto-Heubner-Center for Pediatric and Adolescent Medicine (OHC), Charité, Universitätsmedizin Berlin, Berlin.

出版信息

J Pediatr Hematol Oncol. 2011 Apr;33(3):e105-8. doi: 10.1097/MPH.0b013e31820946d3.

DOI:10.1097/MPH.0b013e31820946d3
PMID:21368673
Abstract

BACKGROUND

The use of anthroposophic medicine (AM) is popular in Central Europe, especially in German-speaking countries. Although these therapies are judged to be beneficial by many patients, there are few data with regard to the safety and efficacy in pediatric oncology. Several theoretical concerns have been published with regard to tumor enhancement or promotion of metastatic dissemination due to mistletoe. To test the indirect safety of supportive anthroposophic treatment accompanying the first-line treatment in children with medulloblastoma in this respect we performed a retrospective matched-pair analysis of patients with medulloblastoma treated by standard first-line radiochemotherapy with or without a concomitantly applied panel of AM including mistletoe. The question was whether the effectiveness of the first-line therapy is altered by AM.

PROCEDURE

Seventeen patients with AM were matched in a 1:2 ratio with 34 patients from the database of the German HIT study group with regard to the criteria of diagnosis, age, status of metastatic dissemination, resection status, and first-line therapy.

RESULTS

The overall survival after 10 years was 58.33% for the AM group and 57.14% for the control group, that is, showing no statistically significant difference (stratified Cox regression; P=0.6023). Event-free survival (including metastases) also did not differ between the groups (stratified Cox regression; P=0.4275).

CONCLUSIONS

AM consisting of different combinations of specific pharmacologic and nonpharmacologic interventions seems to be safe with respect to any potential negative impact on the first-line therapy. There is no evidence with regard to tumor enhancement. The effectiveness of the supportive AM cannot be assessed on the basis of these data.

摘要

相似文献

1
Anthroposophic supportive treatment in children with medulloblastoma receiving first-line therapy.
J Pediatr Hematol Oncol. 2011 Apr;33(3):e105-8. doi: 10.1097/MPH.0b013e31820946d3.
2
Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.肿瘤复发部位对复发性或进展性髓母细胞瘤患儿生存的影响。
J Neurosurg. 2007 Jul;107(1 Suppl):5-10. doi: 10.3171/PED-07/07/005.
3
Medulloblastoma: experience of a single institution.髓母细胞瘤:单一机构的经验
Klin Padiatr. 1998 Jul-Aug;210(4):234-8. doi: 10.1055/s-2008-1043884.
4
Infants with medulloblastoma: a single institution review of survival.髓母细胞瘤患儿:单机构生存情况回顾
Neurosurgery. 1991 Nov;29(5):707-10; discussion 710-1.
5
Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.儿童髓母细胞瘤的放疗与辅助化疗。皇家马斯登医院的经验。
Strahlenther Onkol. 1995 Nov;171(11):615-21.
6
A clinicobiological model predicting survival in medulloblastoma.一种预测髓母细胞瘤患者生存情况的临床生物学模型。
Clin Cancer Res. 2004 Nov 15;10(22):7613-20. doi: 10.1158/1078-0432.CCR-04-0499.
7
Childhood medulloblastoma in Ontario, 1977-1987: population-based results.1977 - 1987年安大略省儿童髓母细胞瘤:基于人群的研究结果
Med Pediatr Oncol. 1996 Jan;26(1):1-9. doi: 10.1002/(SICI)1096-911X(199601)26:1<1::AID-MPO1>3.0.CO;2-Q.
8
Anthroposophic medicine in paediatric oncology in Germany: results of a population-based retrospective parental survey.德国儿科肿瘤学中的人智医学:基于人群的回顾性父母调查结果。
Pediatr Blood Cancer. 2010 Dec 1;55(6):1111-7. doi: 10.1002/pbc.22523.
9
Prognostic factors after extraneural metastasis of medulloblastoma.成神经管细胞瘤颅外转移后的预后因素。
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):72-8. doi: 10.1016/j.ijrobp.2009.07.1729. Epub 2010 Feb 3.
10
[High-dose chemotherapy in relapse of medulloblastoma in young children].[大剂量化疗用于幼儿髓母细胞瘤复发]
Bull Cancer. 1997 Mar;84(3):264-72.

引用本文的文献

1
A systematic review and meta-analysis focusing on the use of ayurvedic medicine in cerebral palsy.一项聚焦阿育吠陀医学在脑瘫治疗中应用的系统评价与荟萃分析。
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):101035. doi: 10.1016/j.jaim.2024.101035. Epub 2024 Oct 1.
2
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up.德国儿科肿瘤强化化疗期间的整合医学:一项 5 年随访的随机对照试验。
BMC Cancer. 2022 Jun 13;22(1):652. doi: 10.1186/s12885-022-09703-0.
3
Supportive mistletoe therapy in a patient with metastasised neuroblastoma.
对一名患有转移性神经母细胞瘤的患者进行支持性槲寄生治疗。
BMJ Case Rep. 2019 Mar 31;12(3):e227652. doi: 10.1136/bcr-2018-227652.
4
Use of complementary and alternative medicine by pediatric oncology patients during palliative care.儿科肿瘤患者在姑息治疗期间使用补充和替代医学的情况。
Support Care Cancer. 2016 Jul;24(7):2869-75. doi: 10.1007/s00520-016-3097-2. Epub 2016 Feb 2.